Pancreatic amyloid is found in more than 95 % of type II diabetes patients. Pancreatic amyloid is formed by the aggregation of islet amyloid polypeptide (hIAPP or amylin), which is a 37-residue peptide. Because pancreatic amyloid is cytotoxic, it is believed that its formation is directly associated with the development of the disease. We recently showed that hIAPP amyloid formation follows the nucleation-dependent polymerization mechanism and proceeds via a conformational transition of soluble hIAPP into aggregated b-sheets. Here, we report that the penta-and hexapeptide sequences, hIAPP(23-27) (FGAIL) and hIAPP(22-27) (NFGAIL) of hIAPP are suf®cient for the formation of b-sheet-containing amyloid ®brils. Although these two peptides differ by only one amino acid residue, they aggregate into completely different ®brillar assemblies. hIAPP(23-27) (FGAIL) ®brils self-assemble laterally into unusually broad ribbons, whereas hIAPP(22-27) (NFGAIL) ®brils coil around each other in a typical amyloid ®bril morphology. hIAPP(20-27) (SNNFGAIL) also aggregates into b-sheet-containing ®brils, whereas no amyloidogenicity is found for hIAPP(24-27) (GAIL), indicating that hIAPP(23-27) (FGAIL) is the shortest ®brillogenic sequence of hIAPP. Insoluble amyloid formation by the partial hIAPP sequences followed kinetics that were consistent with a nucleation-dependent polymerization mechanism. hIAPP(22-27) (NFGAIL), hIAPP(20-27) (SNNFGAIL), and also the known ®brillogenic sequence, hIAPP(20-29) (SNNFGAILSS) exhibited signi®cantly lower kinetic and thermodynamic solubilities than the pentapeptide hIAPP(23-27) (FGAIL). Fibrils formed by all short peptide sequences and also by hIAPP(20-29) were cytotoxic towards the pancreatic cell line RIN5fm, whereas no cytotoxicity was observed for the soluble form of the peptides, a notion that is consistent with hIAPP cytotoxicity. Our results suggest that a penta-and hexapeptide sequence of an appropriate amino acid composition can be suf®cient for b-sheet and amyloid ®bril formation and cytotoxicity and may assist in the rational design of inhibitors of pancreatic amyloid formation or other amyloidosis-related diseases.
Pancreatic amyloid is found in more than 95 % of type II diabetes patients. Pancreatic amyloid is formed by the aggregation of islet amyloid polypeptide (hIAPP or amylin), which is a 37-residue peptide. Because pancreatic amyloid is cytotoxic, it is believed that its formation is directly associated with the development of the disease. We recently showed that hIAPP amyloid formation follows the nucleation-dependent polymerization mechanism and proceeds via a conformational transition of soluble hIAPP into aggregated b-sheets. Here, we report that the penta-and hexapeptide sequences, hIAPP(23-27) (FGAIL) and hIAPP(22-27) (NFGAIL) of hIAPP are suf®cient for the formation of b-sheet-containing amyloid ®brils. Although these two peptides differ by only one amino acid residue, they aggregate into completely different ®brillar assemblies. hIAPP(23-27) (FGAIL) ®brils self-assemble laterally into unusually broad ribbons, whereas hIAPP(22-27) (NFGAIL) ®brils coil around each other in a typical amyloid ®bril morphology. hIAPP(20-27) (SNNFGAIL) also aggregates into b-sheet-containing ®brils, whereas no amyloidogenicity is found for hIAPP(24-27) (GAIL), indicating that hIAPP(23-27) (FGAIL) is the shortest ®brillogenic sequence of hIAPP. Insoluble amyloid formation by the partial hIAPP sequences followed kinetics that were consistent with a nucleation-dependent polymerization mechanism. hIAPP(22-27) (NFGAIL), hIAPP(20-27) (SNNFGAIL), and also the known ®brillogenic sequence, hIAPP(20-29) (SNNFGAILSS) exhibited signi®cantly lower kinetic and thermodynamic solubilities than the pentapeptide hIAPP (23) (24) (25) (26) (27) (FGAIL) . Fibrils formed by all short peptide sequences and also by hIAPP (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) were cytotoxic towards the pancreatic cell line RIN5fm, whereas no cytotoxicity was observed for the soluble form of the peptides, a notion that is consistent with hIAPP cytotoxicity. Our results suggest that a penta-and hexapeptide sequence of an appropriate amino acid composition can be suf®cient for b-sheet and amyloid ®bril formation and cytotoxicity and may assist in the rational design of inhibitors of pancreatic amyloid formation or other amyloidosis-related diseases.
Introduction
Amyloid formation is the pathological hallmark of a number of diseases including Alzheimer's disease (AD), the prion protein-related encephalopathies and type II diabetes Lansbury, 1996; Sipe, 1994) . Although amyloid ®brils originate from different proteins, they share similar physicochemical properties including morphology and insolubility Sipe, 1994) . At the level of secondary structure, amyloid from different polypeptides consists of peptide chains in a predominant b-sheet conformation (Ashburn et al., 1992; Ashburn & Lansbury, 1993; Gasset et al., 1992; Glenner et al., 1988; Hilbich et al., 1991; Inouye et al., 1993; .
Pancreatic amyloid in humans forms through the aggregation of islet amyloid polypeptide (hIAPP), which is a 37-amino acid residue polypeptide (Scheme 1) Cooper et al., 1987; Rink et al., 1993; Westermark et al., 1987) . hIAPP-derived amyloid is found in more than 95 % of type II diabetes patients and is believed to be directly related to b-cell dysfunction and the pathogenesis of the disease de Koning et al., 1993; Luskey, 1992) . hIAPP in its soluble form is thought to play a role in glucose homeostasis, possibly as an insulin counter-regulatory hormone (Edwards & Morley, 1992; Rink et al., 1993) . However, ®brillar aggregates of hIAPP have been found to be strongly toxic on pancreatic b-cells .
Although the sequence of IAPP is strongly conserved over a number of animal species, IAPPderived amyloid is only formed by humans, cats, and some non-human primates (Westermark et al., 1990) . Rodents do not form pancreatic amyloid, although there are only six amino acid residues by which the rat sequence (rIAPP) differs from its human (hIAPP) analog (Westermark et al., 1990) . Five of these six amino acid residues are located in the region between residues 20 and 29 (Scheme 1). Therefore, the amyloidogenicity of hIAPP has been related to amino acids in the sequence (20-29) (Ashburn & Lansbury, 1993; Moriarty & Raleigh, 1999; Westermark et al., 1990) . Moreover, the decapeptide hIAPP(20-29) has been found to form ®brils that most likely contain the peptide in a highly pleated antiparallel b-sheet conformation and in a morphology that is similar to the ®brils formed by the complete hIAPP sequence (Glenner et al., 1988; Grif®ths et al., 1995; Moriarty & Raleigh, 1999) . Thus, has been the shortest reported hIAPP sequence with ®brillo-genic potential to date (Glenner et al., 1988; Moriarty & Raleigh, 1999) . We have recently shown that a conformational transition of soluble IAPP into b-sheets precedes in vitro hIAPP insolubilization into ®brils (Kayed et al., 1999) . In addition, we have shown that the kinetics of hIAPP amyloid formation are consistent with the Scheme 1. Primary sequence of hIAPP, rIAPP, and the synthetic peptide sequences that were synthesized and studied. hIAPP and rIAPP contain a C-terminal amide and a disul®de bridge between Cys2 and Cys7 that are not shown. Residues in bold in rIAPP or in the partial rIAPP sequences indicate those amino acids of rIAPP that differ from hIAPP. nucleation-dependent polymerization mechanism Kayed et al., 1999) .
Here, we focus on the identi®cation of the shortest sequence of hIAPP which is able to self-assemble into b-sheets and amyloid. Secondary structure prediction analysis of the (20-29) region of hIAPP was performed ®rst and the sequences that were predicted to form b-sheet structures and appropriate control-sequences were synthesized. Kinetics of insoluble ®bril formation were studied by turbidity measurements at 400 nm and their ®brillogenic potentials evaluated by electron microscopy (EM), atomic force microscopy (AFM), and the Congo red (CR) staining method. Conformations of insoluble peptide aggregates were studied by Fourier transform infrared (FT-IR) spectroscopy. Finally, the effect of the short hIAPP sequences on cell viability of a pancreatic cell line was examined.
Results

Identification of minimum length IAPP sequences with fibrillogenic potential
We ®rst performed secondary structure prediction analysis of hIAPP(20-29) (SNNFGAILSS), which was established to represent an amyloidogenic sequence of IAPP (Ashburn et al., 1992; Ashburn & Lansbury, 1993; Moriarty & Raleigh, 1999; Westermark et al., 1990) , by the method described by Chou & Fasman (1978) , and found that hIAPP(23-27) (FGAIL) could potentially be the shortest sequence with b-sheet-forming potential. By contrast, no b-sheet-forming potential was predicted for the corresponding rat sequence, rIAPP(23-27) (LGPVL). Since the amyloidogenicity of a peptide sequence has been described to be often closely related to its b-sheet-forming propensity (Ashburn et al., 1992; Ashburn & Lansbury, 1993; Moriarty & Raleigh, 1999) , we hypothesized that the sequence hIAPP(23-27) (FGAIL) could be ®brillo-genic. Such an assumption was supported by rotational resonance solid-state NMR (R 2 -SSNMR) studies that have suggested that the basic unit of the hIAPP(20-29) (SNNFGAILSS) ®bril may contain the FGAIL sequence in a self-assembled, intermolecular b-sheet con®guration (Grif®ths et al., 1995) .
We synthesized hIAPP(23-27) (FGAIL) as well as the longer and shorter analogs hIAPP(22-27) (NFGAIL) and hIAPP(24-27) (GAIL), respectively (Scheme 1).
Sequences hIAPP(20-29) (SNN FGAILSS), a scrambled version of hIAPP(22-27) (LIAGFN), rIAPP(20-29) (SNNLGPVLPP), and rIAPP(22-27) (NLGPVL) were also synthesized and used as controls for b-sheet-forming and amyloidogenic or non-amyloidogenic sequences, respectively (Westermark et al., 1990) .
We then tested the ®brillogenic potential of these peptides by EM and AFM. Following aging of a highly concentrated aqueous solution (3.7-9.3 mg/ ml, four to six days incubation time in phosphate buffer (pH 7.4) or in water), the tetrapeptide hIAPP(24-27) (GAIL) remained soluble. AFM examination con®rmed that no ®brils were present in the hIAPP(24-27) (GAIL) solutions. Instead, round and punctuate aggregates formed when the solution was allowed to dry (Figure 1(a) ). By contrast, supersaturated and aged aqueous suspensions of hIAPP(23-27) (FGAIL) and hIAPP(22-27) (NFGAIL) (tested apparent peptide concentrations were 2.6-5.2 mg/ml for FGAIL and 3.2-6.4 mg/ml for NFGAIL, in phosphate buffer (pH 7.4), or water, four to six days incubation time) were found to consist exclusively of amyloid-like ®brils and ®bril bundles (Figures 1(b) and (c), and 2(a) and (b)). Although these two peptide sequences differ by only one residue, their ®brillar assemblies were completely different. hIAPP(23-27) (FGAIL) ®brils generally aligned laterally with each other to yield very long (>3 mm) and broad (> 300 nm) ribbon-like ®bril bundles (Figures 1(b) and 2(a) and (b)). By contrast, hIAPP(22-27) (NFGAIL) ®laments coiled along each other and resulted in ®brils with properties that have been well described for amyloids, i.e. an axial helical periodicity (about 200 nm) (Goldsbury et al., 1997 (Goldsbury et al., , 1999 Harper et al., 1997a,b; Stine et al., 1996) . Of note, no propensity towards a parallel alignment, as seen with the hIAPP(23-27) (FGAIL) ®laments, was observed for hIAPP(22-27) (NFGAIL) (Figure 1(c) ). Judging from the EM measurements, hIAPP(22-27) (NFGAIL) ®brils had diameters of about 15 to 20 nm. However, it should be noted that the observed branching and coiling features of the hIAPP(22-27) (NFGAIL) ®brils (Figure 1(c) ) suggested that the diameters measured represented an assembly of at least two ®laments (Harper et al., 1997a,b) . A majority of isolated hIAPP(23-27) (FGAIL) ®brils, which may also represent an assembly of at least two ®laments, had diameters of about 17 nm according to AFM.
Aged and saturated solutions of hIAPP(20-27) (SNNFGAIL) and hIAPP(20-29) (SNNFGAILSS) also formed ®brils and ®bril bundles (Figure 1(d) and (e)). Fibrils of hIAPP(20-27) (SNNFGAIL) showed a similar helical coiling around each other as seen for the hIAPP(20-27) (NFGAIL) ®brils and had diameters of about 6 to 10 nm, as estimated by EM. By contrast, ®laments of hIAPP(20-29) (SNNFGAILSS) had a strong propensity to laterally self-assemble into a net of broad ribbons. No ®bril formation was observed in aged incubations of highly concentrated solutions (6.4 mg/ml or 10 mM) of the scrambled hIAPP(22-27) control peptide LIAGFN. These solutions, when dried, exclusively consisted of amorphous aggregates (Figure 1(f) ). Similarly, highly concentrated solutions of the soluble rat sequences rIAPP(22-27) (NLGPVL) (6.1 mg/ml or 10 mM) (Figure 1(g) ) and rIAPP(20-29) (SNNLGPVLPP) (10 mg/ml or 10 mM) (data not shown) consisted of amorphous aggregates only.
We then applied the CR staining method combined with polarization microscopy to test for amyloidogenicity of the IAPP sequences. Amyloid ®brils in general, and ®brillar hIAPP in particular, bind CR and exhibit a gold/green birefringence under polarized light (Cooper, 1974; . Aged hIAPP(23-27) (FGAIL) and hIAPP(22-27) (NFGAIL) suspensions (2.6-5.2 mg/ml for FGAIL and 3.2-6.4 mg/ml for NFGAIL, in phosphate buffer (pH 7.4), aged for four days) bound CR and exhibited the characteristic green/gold birefringence (Figure 3 d) for polarized microscopy of hIAPP(22-27) (NFGAIL)). hIAPP(20-27) (SNNFGAIL) also stained with CR and showed strong birefringence (not shown). As a control, aged, supersaturated solutions of hIAPP(20-29) (SNNFGAILSS) were also examined and were found to exhibit strong green/gold birefringence, whereas no CR binding was found for aged solutions of rIAPP(22-27) (NLGPVL) and rIAPP(20-29) (SNNLGPVLPP) (not shown). Interestingly, aged and highly concentrated solutions of hIAPP(24-27) (GAIL) (25 mM or 9.3 mg/ml), when allowed to dry, yielded long needles that were visible by light microscopy. These needles appeared birefringent with and Taken together, the results of the EM, AFM, and CR analyses strongly suggested that hIAPP(23-27) (FGAIL) is the shortest hIAPP sequence necessary for amyloid formation.
Aggregation kinetics of the hIAPP sequences
Aggregation of several amyloid-forming polypeptides in vitro has been suggested to proceed by nucleation-dependent polymerization (Ashburn & Lansbury, 1993; Harper & Lansbury, 1997; . The existence of a lag-time prior to protein aggregation, which is partially or completely eliminated by the addition of preformed aggregates or seeds, is a characteristic feature of this mechanism. To study self-assembly of our amyloidogenic sequences, we followed their aggregation and insolubilization kinetics by turbidity measurements at 400 nm ( Figure 4 ) (Ashburn & Lansbury, 1993; Harper & Lansbury, 1997; . In another series of experiments, the results of the turbidity assays were independently con®rmed by the CR binding assay (data not shown) (Klunk et al., 1989a,b) .
For the kinetic aggregation assays, several solvents for preparation of stock solutions and various peptide concentrations were tested to obtain reproducible aggregation kinetics. This was necessary due to the various experimental factors that may strongly affect aggregation kinetics of supersaturated solutions, which are inherently metastable (Harper & Lansbury, 1997; Kayed et al., 1999) . For the preparation of the peptide stocks, acetonitrile (ACN) and 1,1,1,3,3,3-hexa¯uoro-2-propanol were among those examined. As hIAPP(20-27) (SNNFGAIL) and hIAPP(20-29) (SNNFGAILSS) were insoluble in these solvents at the required concentrations, stock solutions of all peptide sequences were eventually prepared in dimethyl sulfoxide (DMSO) and used immediately to avoid formation of pre-aggregated peptide seeds . DMSO is broadly applied as a disaggregating solvent, especially for the preparation of stock solutions of amyloidogenic peptides including sequences of hIAPP (Ashburn & Lansbury, 1993; Harper et al., 1997b; . However, the possibility that stock solutions prepared in DMSO may also contain minute amounts of seeds cannot be completely excluded. Filtering of the solutions was not possible due to strong nonspeci®c binding of the peptides to various ®lter membranes. Yet, the observed concentration dependence of the lag-time (data not shown) and the reproducibility of our results indicated that our fresh stock solutions most likely did not contain aggregation nuclei.
The kinetic pro®les of insoluble amyloid formation observed for all short sequences were strongly indicative of a nucleation-dependent polymerization mechanism . After a lag-time of 30 hours, hIAPP(23-27) (FGAIL) (2.6 mg/ml in phosphate buffer and 4 % DMSO, pH 7.4) rapidly self-assembled into insoluble amyloid ®brils (Figure 4 ). Aggregation of hIAPP(22-27) (NFGAIL) at an identical apparent molar concentration (3.2 mg/ml) exhibited a signi®cantly shorter lag-time of only 42 minutes (Figure 4 ), indicating a lower kinetic solubility for this sequence. hIAPP(20-27) (SNNFGAIL) and the strongly amyloidogenic sequence hIAPP(20-29) (SNNFGAILSS) immediately aggregated under the above conditions (Figure 4) (Ashburn & Lansbury, 1993) . By contrast, hIAPP(24-27) (GAIL) was highly soluble in aqueous buffer and did not aggregate under these conditions neither at fourfold higher molar concentrations than those applied for the other sequences (Figure 4 ). Of note, because the molecular mass of the various self-associated peptide species is unknown, the concentrations of the amyloidogenic sequences are generally presented as mass per volume measures. To compare the biophysical properties (®bril-and b-sheet-forming potentials, solubilities and cytotoxicities) of the different peptide sequences, solutions or suspensions of identical``apparent'' molar concentrations were applied, indicated by the use of molar concentration units. Molarities were calculated based on the molecular mass of the monomers, assuming that the peptides were monomeric and completely soluble.
Kinetic aggregation studies of the amyloidogenic fragments at various peptide concentrations indicated that the length of the lag-time was inversely related to the apparent peptide concentration (data not shown), which is another characteristic feature of nucleation-dependent polymerization . Of importance, the observed lagtimes of aggregation for hIAPP(23-27) (FGAIL) and (22-27) (NFGAIL) were immediately eliminated by seeding, further adding to the notion that amyloid formation by the short hIAPP sequences was nucleation-dependent ( Figure 5(a) and (b) ).
In agreement with previous reports , the thermodynamic solubilities of the hIAPP sequences were found to depend strongly on the speci®c peptide sequence. Thermodynamic solubilities were determined by quanti®-cation of the amount of soluble peptide at the point of thermodynamic equilibrium which was usually after four days following the beginning of the aggregation experiment (Ashburn & Lansbury, 1993; . In the post-nucleation equilibrium, hIAPP(23-27) (FGAIL) exhibited the highest thermodynamic Figure 3 . Examination of the amyloidogenic nature of partial hIAPP fragments by the Congo red (CR) binding assay. Normal ®eld microscopic examination of aged solutions of (a) hIAPP(23-27) (FGAIL), (c) hIAPP(22-27) (NFGAIL), and (e) hIAPP(24-27) (GAIL) following staining with CR is shown. Microscopic examination under polarized light of (b) hIAPP(23-27) (FGAIL), (d) hIAPP(22-27) (NFGAIL), and (f) hIAPP(24-27) (GAIL) is also shown. Supersaturated solutions were prepared and aged for four days as described in Materials and Methods. solubility (1.4(AE0.2) mg/ml) and hIAPP(20-29) (SNNFGAILSS) the lowest one (0.3(AE0.1) mg/ml), while hIAPP(20-27) (SNNFGAIL) exhibited a thermodynamic solubility that was similar to hIAPP(20-29) (0.5(AE0.1) mg/ml) (mean(AESEM) of at least three independent aggregation assays). Interestingly, a 40 % higher insolubility on a molar basis was found for hIAPP(22-27) (NFGAIL) (thermodynamic solubility: 1.2(AE0.2) mg/ml), as compared to hIAPP(23-27) (FGAIL). . Kinetics of insoluble amyloid formation of partial hIAPP sequences as followed by turbidity at 400 nm. Turbidity of aqueous solutions of hIAPP(24-27) (GAIL), (23-27) (FGAIL), and (22-27) (NFGAIL) in 10 mM phosphate buffer (pH 7.4), and 4 % DMSO (apparent peptide concentrations were 5 mM) prepared as described in Materials and Methods was followed for several hours. Inset: Kinetics of aggregation of hIAPP sequences (20-27) (SNNFGAIL) and (20-29) (SNNFGAILSS) under the same experimental conditions as for the shorter sequences are shown (time-scale: minutes). Turbidity of aqueous solutions (apparent peptide concentrations were 5 mM) was measured and solutions prepared as described in Materials and Methods. Data are from one representative experiment of at least three performed. Figure 5 . Nucleation of amyloid formation by hIAPP sequences (23-27) (FGAIL) and (22-27) (NFGAIL) via addition of traces of preformed ®brils. Kinetics of amyloid formation are followed by turbidity measurement at 400 nm for seeded and non-seeded (a) hIAPP(23-27) (FGAIL) (2.6 mg/ml) and (b) hIAPP(22-27) (NFGAIL) (2.4 mg/ml) as indicated. Seeding was performed with 10 % preformed (a) hIAPP(23-27) (FGAIL) ®brils and (b) hIAPP(22-27) (NFGAIL) ®brils as described in Materials and Methods. Data are from one representative experiment of at least three performed.
Conformation of the hIAPP sequences in their fibrillar state as determined by FT-IR FT-IR spectroscopic studies of the aggregates of the amyloidogenic partial sequences and also of highly concentrated and aged (3.7 mg/ml or 10 mM, incubation time of four days) solutions of hIAPP(24-27) (GAIL) were then performed. The ®brillar aggregates were obtained from the kinetic aggregation assays and were collected after four days of aggregation. FT-IR spectra typical for a random coil structure mixed with various different conformations were recorded for aged hIAPP(24-27) (GAIL) solutions (Figure 6(a) ). By contrast, a sharp absorbance maximum at 1633 cm À1 was found in the spectrum of hIAPP(23-27) (FGAIL) ®brils. Such an absorbance is typically assigned to b-sheet structures (Krimm & Bandekar, 1986; (Figure 6(b) ). hIAPP(22-27) (NFGAIL) ®brils produced a spectrum with a markedly broader absorbance maximum at 1633 cm À1 and a strong shoulder at 1666 cm À1 , indicating the presence of b-structures mixed with signi®cant amounts of non-b structures, i.e. random coil and turns (Figure 6(c) ). The spectra of the ®brils of hIAPP(20-27) (SNNFGAIL) and hIAPP(20-29) (SNNFGAILSS) had pronounced maxima at 1633 cm À1 and 1625 cm À1 , respectively, suggesting signi®cant b-sheet contents (Figure 6(d) and (e)) (Ashburn et al., 1992; Ashburn & Lansbury, 1993; Glenner et al., 1988; Moriarty & Raleigh, 1999) . By contrast, aged and highly concentrated solutions of the reported non-amyloidogenic rIAPP(20-29) (SNNLGPVLPP) (10 mM or 10.1 mg/ml in 2 H 2 O) (not shown) and rIAPP(22-27) (NLGPVL) (10 mM or 6.1 mg/ml in 2 H 2 O), (Figure 6(f) ), gave FT-IR spectra that indicated that non-b conformations were predominant.
Effect of the hIAPP fragments on the viability of a pancreatic b b b-cell line There are several lines of evidence suggesting an association between the pathology of the various amyloidoses and the cytotoxicity of the ®brillar forms of the respective amyloid-forming peptides, including b-amyloid peptide (Ab), prion protein, and hIAPP (Forloni et al., 1994; Iversen et al., 1995; Pike et al., 1991 Pike et al., , 1995 . We used the insulin-producing pancreatic cell line RIN5mf (Nishi et al., 1989) to test the cytotoxic effect of fragments hIAPP(23-27) (FGAIL), (22-27) (NFGAIL), (20-27) (SNNFGAIL), and (20-29) (SNNFGAILSS). In preliminary studies, a strong cytotoxic effect of the complete hIAPP sequence on this cell line was found (data not shown); its effective apparent concentration that caused 50 % cell damage (EC 50 ) following a 20 hours incubation was 1.2 nM. For the assessment of peptide toxicity, an assay based on the cellular reduction of the dye 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) was used (Kapurniotu et al., 1998; Schubert et al., 1995; Shearman et al., 1995 Shearman et al., , 1994 .
We ®rst tested the effect of preformed ®brillar aggregates of hIAPP(23-27) (FGAIL), (22-27) (NFGAIL), (20-27) (SNNFGAIL), and (20-29) (SNNFGAILSS) obtained from the kinetic aggregation experiments (see above). Fibrillar aggregates were collected after aggregations had reached a thermodynamic equilibrium (four days), quanti®ed, and added to the cells. We found signi®cant cytotoxicities for the preformed ®brillar aggregates of the known amyloidogenic sequence hIAPP(20-29) (SNNFGAILSS) as well as for the aggregates of hIAPP(23-27) (FGAIL) and (22-27) (NFGAIL) that were similarily cytotoxic to hIAPP(20-29) (Figure 7(a) ). Of note, cytotoxicities of these peptides were about 1000-fold lower on a molar basis , and hIAPP(20-29) (SNNFGAILSS) were dissolved in cell culture medium at an apparent concentration of 500 mM and then immediately added to the cells at an apparent ®nal concentration of 50 mM. Fibrillar aggregates were also applied onto cells at apparent concentrations of 50 mM. Following incubation, cytotoxicities were assessed as described in (a). Data are percentages of control values (vehicle alone) and are the mean (AESEM) of three independent experiments with each experiment performed in multiple replicates (n 6) except for the data of hIAPP(20-27) which are derived from one representative experiment performed in n 12 replicates.
than that of the complete hIAPP sequence. The aggregates of hIAPP (20-27) (SNNFGAIL) were slightly less toxic than the aggregates of the three other peptide fragments (Figure 7(a) ). As a negative control, sequence LIAGFN that was previously found to be non-amyloidogenic was tested following aging and no cytotoxicity was found. To control for possible reported effects of DMSO on cytotoxicity (Mattson et al., 1992) , peptide ®brils were also prepared by dissolving or suspending the peptides in H 2 O followed by aging for four days prior to application onto the cells. Under these conditions, the same cytotoxicities were observed as for the peptide stocks prepared in DMSO.
We then tested the cytotoxic effect of the freshly dissolved peptides. Peptide stock solutions of the partial sequences were prepared by directly dissolving the lyophilized peptides in cell medium and at an apparent concentration of 500 mM. While the solutions of peptides (24-27) (GAIL), (23-27) (FGAIL), (22-27) (NFGAIL), and (20-27) (SNNFGAIL) did not contain ®brils at the time point of their preparation, the stock solutions of hIAPP and (20-29) (SNNFGAILSS) already contained some ®brillar aggregates due to their low kinetic solubilities. The absence or presence of ®brils at the time of preparation of the stock solutions was veri®ed by EM (not shown). Incubation of the cells with freshly dissolved hIAPP(24-27) (GAIL), (23-27) (FGAIL), (22-27) (NFGAIL), and (20-27) (SNNFGAIL) for about 20 hours did not affect cell viability, whereas non-aged but ®bril-containing hIAPP(20-29) (SNNFGAILSS) was as cytotoxic as its ®brillar form (Figure 7(b) ). No insoluble peptide aggregates on or between the cells could be detected by light microscopic examination of the incubations with hIAPP(23-27) (FGAIL), (22-27) (NFGAIL), and (20-27) (SNNFGAIL), whereas signi®cant amounts of such aggregates were observed in the hIAPP(20-29) (SNNFGAILSS) or hIAPP incubations. Thus, it is likely that peptides hIAPP(23-27) (FGAIL), (22-27) (NFGAIL), and (20-27) (SNNFGAIL), due to their high degree of solubility and their long aggregational lag-times, remained in their soluble forms during the 20 hour incubation period, suggesting that the soluble forms are likely non-toxic.
Discussion
There is increasing evidence suggesting a direct association of aggregation and ®bril formation by amyloid-forming polypeptides with the pathologic sequelae of amyloidosis-related diseases, including prion-protein related encephalopathies, AD, and type II diabetes Forloni et al., 1994; Iversen et al., 1995; Pike et al., 1991 Pike et al., , 1995 Schubert et al., 1995; Thomas et al., 1995) . Amyloid consists of polypeptide chains that are predominantly in a b-sheet conformation (Ashburn et al., 1992; Ashburn & Lansbury, 1993; Gasset et al., 1992; Hilbich et al., 1991; Inouye et al., 1993; Zhang & Rich, 1997) . The b-sheet-forming propensity of a peptide chain has been shown to be closely related to its ability to aggregate into amyloid ®brils (Ashburn et al., 1992; Ashburn & Lansbury, 1993; Gasset et al., 1992; Glenner et al., 1988; Grif®ths et al., 1995; Hilbich et al., 1991; Kapurniotu et al., 1998; Kayed et al., 1999; Kominos, 1995; Lansbury, 1996; Moriarty & Raleigh, 1999; Pike et al., 1995) . Aggregation and amyloid formation by Ab and hIAPP have been suggested to proceed via a common molecular mechanism that includes a conformational transition from soluble, non-toxic peptide conformers into b-sheet-containing amyloid precursors (Kayed et al., 1999; Pike et al., 1995; Shen & Murphy, 1995; Soto & Frangione, 1995) .
Our studies aimed to identify the shortest sequence of hIAPP capable of forming b-sheets and amyloid. Secondary structure predictions indicated that the sequence hIAPP(23-27) (FGAIL) could be the shortest hIAPP sequence with a b-sheet-forming potential. In fact, aged suspensions of sequences (23-27) (FGAIL), (22-27) (NFGAIL), (20-27) (SNNFGAIL), and (20-29) (SNNFGAILSS) were found to exclusively consist of long ®brils and ®bril bundles. While the amyloidogenicity of sequence (20-29) was already known (Ashburn & Lansbury, 1993; Moriarty & Raleigh, 1999; Westermark et al., 1990; Glenner et al., 1988) , there had been no reports with regard to ®bril formation by sequences of amyloidogenic polypeptides as short as the penta-or hexapeptides investigated here. To our knowledge, the shortest sequences that have been reported to be able to form amyloid ®brils consist of at least eight amino acid residues. These are the octapeptide AGAAAAGA of the prion protein and a ten residue peptide of Ab (Lundberg et al., 1997; Tjernberg et al., 1999) .
The ®laments of hIAPP sequence (23-27) (FGAIL) showed a strong propensity to laterally self-associate into very broad ribbons, whereas the ®laments formed by sequences (22-27) (NFGAIL) and (20-27) (SNNFGAIL) were long and thin and coiled laterally around each other to yield ®bril bundles of pronounced axial helical twisting. A lateral helical coiling of ®laments around each other has often been described in amyloid ®brils from several different polypeptides, suggesting that this packing might represent a common ®lament selfassembly mechanism (Goldsbury et al., 1997 (Goldsbury et al., , 1999 Harper et al., 1997a,b; Stine et al., 1996) . On the other hand, studies on Ab have previously related the formation of ribbon-like arrays to the decreased ability of the ®laments to pack laterally in the typical coiled ®ber morphology (Fraser et al., 1994) . hIAPP has been reported to form ®brils that are characterized by a structural polymorphism, and two mechanisms of hIAPP ®brillar self-assembly have been proposed. These include the lateral assembly into ribbon-or sheet-like arrays and ®la-ment coiling into coiled ®brils (Goldsbury et al., 1997 (Goldsbury et al., , 1999 . Thus, the ®brillar assemblies formed by hIAPP(23-27) (FGAIL) and hIAPP(22-27) (NFGAIL) seem to have formed by both self-association mechanisms in a sequence-dependent manner. The striking differences between the morphologies of the ®laments of the two sequences that differ by only one amino acid residue (Asn22) strongly suggest that this residue plays an important role in directing self-assembly and lateral packing of ®laments. Such a role could be that its side-chain could be involved in intermolecular side-chain interactions that lead to a ®lament-stabilizing self-association as previously proposed for proto®lament assembly of Ab (Fraser et al., 1994) . The importance of residue Asn22 for ®bril formation was also con®rmed by our kinetic aggregation data and has been also pointed out in a very recent study by Moriarty & Raleigh (1999) .
FT-IR spectroscopy of the ®brils of the partial hIAPP sequences suggested that they all contain signi®cant amounts of b-sheet structure (Ashburn et al., 1992; Ashburn & Lansbury, 1993; Grif®ths et al., 1995) . According to the R 2 -SSNMR model of pancreatic amyloid ®brils, hIAPP(23-27) (FGAIL) is strongly constrained in an intermolecular antiparallel b-sheet, and a number of the sheet-stabilizing intermolecular interactions in hIAPP(20-29) (SNNFGAILSS) ®brils were found to occur between residues in this peptide region (Grif®ths et al., 1995) . These results are in good agreement with the high b-sheet and amyloidogenic propensity of hIAPP(23-27) (FGAIL) as found in our work, and suggest that FGAIL could be the core of the hIAPP ®bril.
The sequence motif GAIL is common in the two amyloidogenic IAPP sequences from cat and man, and has previously been suggested to be crucial for their amyloidogenicity (Ashburn et al., 1992; Ashburn & Lansbury, 1993; Grif®ths et al., 1995; Westermark et al., 1990) . We found, however, that this tetrapeptide alone is not able to aggregate into b-sheets and amyloid-like ®brils in aqueous solutions, whereas its N-terminal extension by only one residue results in the strongly amyloidogenic hIAPP(23-27) (FGAIL). Nevertheless, (24-27) (GAIL) was also found to have a strong propensity to form ordered structures.
Measurement of the kinetics of amyloid formation is a complicated process due to the large number of different self-associated species and the variability of their physical properties (Harper & Lansbury, 1997) . Therefore, several methods are used, often complementary to each other, to obtain independent information about the kinetics of amyloid formation. We used turbidity measurements at 400 nm to follow the kinetics of insoluble ®bril formation (Ashburn & Lansbury, 1993; Harper & Lansbury, 1997; . It should be noted that turbidity measurements at 400 nm only allow for the detection of aggregates with diameters larger than the wavelength of the incident light beam. Thus, formation of small size and possibly visibly soluble aggregates may be not detectable, and it has been reported that there are amyloid ®brils that do not exhibit turbidity at 400 nm (Harper & Lansbury, 1997; Wood et al., 1996) . However, the turbiditybased assays are able to detect formation of insoluble amyloid and, therefore, the results of our turbidity assays refer to kinetics of insoluble amyloid formation (Ashburn & Lansbury, 1993; Harper & Lansbury, 1997; . Furthermore, the aggregation assays presented here were performed under stirring conditions, which has been suggested to possibly generate small ®brils that exhibit turbidity, contrary to ®brils formed in non-stirred solutions (Wood et al., 1996) .
Thio¯avine T and CR-amyloid binding-based assays are used for the kinetic follow up of aggregation and amyloid formation (Klunk et al., 1989a,b; LeVine, 1993b; Harper & Lansbury, 1997; Wood et al., 1996 Wood et al., , 1995 . The exact structural and conformational features of amyloid-forming peptides responsible for binding to both compounds and the binding-induced spectral shifts are not yet understood, and among other factors depend on ®bril morphology (Klunk et al., 1989a,b; Harper & Lansbury, 1997; Wood et al., 1996) . According to one report, hIAPP amyloid fails to induce the typical change in the¯uorescence spectrum of thio¯a-vin T, thus precluding the use of this dye to follow the kinetics of hIAPP amyloid formation (LeVine, 1993a) . By contrast, hIAPP amyloid readily binds to CR (Kayed et al., 1999; . Ab ®brils that were visibly soluble and did not exhibit turbidity at 405 nm were shown to bind to CR (Wood et al., 1996) . To exclude the possibility that amyloid ®brils that were not detectable by the turbidity assay were already present during the lag-time of our aggregational times, we measured the aggregation kinetics of of hIAPP(23-27) and hIAPP(22-27) by both turbidity and CRbinding. Identical aggregation kinetics pro®les were obtained for the same aggregation solution by both methods, which con®rmed the validity of the results of the turbidity assay.
Amyloid formation processes of all amyloidogenic sequences of hIAPP were found to follow kinetics that were consistent with the nucleationdependent polymerization . Kinetic solubilities were in the order hIAPP(23-27) (FGAIL) < hIAPP(22-27) (NFGAIL) 5hIAPP(20-27) (SNNFGAIL) < hIAPP(20-29) (SNN FGAILSS). The thermodynamic solubilities were in the same order. Thus, the differences in the apparent (kinetic) solubilities between these sequences are due to both kinetic and thermodynamic effects. The large kinetic and thermodynamic solubilities of hIAPP(23-27) (FGAIL) suggested that the high b-sheet contents of its ®brillar form did not contribute signi®cantly to ®bril formation rates and stability, factors that may be closely related to monomer association and the ®bril dissociation equilibrium constants. Thus, the b-sheet content of ®brils of a particular sequence may not necessarily re¯ect its kinetic and thermodynamic solubilities. The observed low kinetic and thermodynamic solubilities of the longer partial hIAPP sequences may be due to additional ®bril-stabilizing interactions, i.e. hydrophobic interactions that could play a role in a longer sequence, whereas the high entropic cost of self-association would inhibit such an effect in the short sequences Weinreb et al., 1994) .
All ®brillar aggregates were cytotoxic to a pancreatic b-cell line, whereas the soluble forms of the peptide fragments showed no toxicity. These ®nd-ings were consistent with the previously described strong toxicity of hIAPP ®brils and the lack of toxicity of soluble hIAPP, and show for the ®rst time that ®brils of hIAPP(20-29) are also cytotoxic May et al., 1993) . Interestingly, the fragments that were studied were about 1000-fold less toxic than ®brillar hIAPP. A possible reason that may account for this ®nding might be their about 100 to 1000-fold higher kinetic and/or thermodynamic solubilities as compared to the highly insoluble hIAPP (Kayed et al., 1999) . This would affect both their aggregational lag-time and the stability of their ®brils towards dissociation .
Here, we show that penta-and hexapeptide sequences of hIAPP, hIAPP(23-27) (FGAIL) and hIAPP(22-27) (NFGAIL), are suf®cient for b-sheet and cytotoxic amyloid ®bril formation. Our studies also suggest that, apart from the b-sheet structure itself, there are several yet unidenti®ed conformational features that may be involved in the mechanism of peptide self-assembly into ®brils. Our results con®rm the dependence of cytotoxicity of an amyloid-forming peptide on its molecular assembly form (Burdick et al., 1992; Iversen et al., 1995; Pike et al., 1991 Pike et al., , 1995 . Short sequences containing crucial residues for amyloid formation and their analogs have been recently used as b-sheet breakers and inhibitors of Ab amyloid formation (Soto et al., 1998) . Thus, the synthetic peptide sequences presented here or rationally designed analogs thereof may ®nd therapeutic applications, since they could be used as, or assist in, the development of inhibitors of pancreatic amyloid formation.
Materials and Methods
Peptide synthesis
Syntheses were performed by solid-phase synthetic protocols on 4-alkoxybenzyl alcohol resin from Bachem (Heidelberg, Germany) using the 9-¯uorenylmethoxycar-bonyl (Fmoc) protecting group for protection of the N a -amino group, the tert-butyl group (tBu) for protection of the side-chain of the Ser residue and the trityl group (Trt) for the side-chain of the Asn residue. Couplings were performed by 2-(1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium tetra¯uoroborate (TBTU) and a threefold excess of protected amino acids (Bachem, Heidelberg, Germany) and coupling reagent was used. Deprotected peptides were obtained by treatment of the peptide-resin with 95 % (v/v) tri¯uoracetic acid (TFA) at room temperature for two hours, followed by TFA evaporation in vacuum at 30 C. Crude peptides were either dissolved in acetic acid and precipitated by the addition of chilled diethyl ether, the pellets dried in vacuum, redissolved in 10 % (v/v) acetic acid and lyophilized, or dissolved in 10 % acetic acid, washed with diethyl ether and lyophilized. Peptides were puri®ed by reverse-phase high-pressure liquid chromatography (RP-HPLC) on a Nucleosil 100 C-18 semi-preparative column (Grom, Herrenberg, Germany) (100 A Ê pore size, 7-mm paricle size, 8 mm Â 250 mm). Flow rate was 2 ml/minute and the linear gradient used was from 10 % to 90 % eluent B in 30 minutes. Eluents used were: A: 10 % acetonitrile (ACN) in water and 0.058 % tri¯uoracetic acid (TFA); and B: 90 % ACN in water and 0.05 % TFA. Characterization of the HPLC-puri®ed peptides was performed by fast-atom bombardment mass spectroscopy (FAB-MS) or laser desorption mass spectroscopy (LD-MS) and purity was further con®rmed by analytical RP-HPLC.
Kinetic aggregation assays
Stock solutions for the assays with ®nal apparent peptide concentrations of 5 mM (1.8-5 mg/ml, depending on the sequence) were prepared by dissolving lyophilized forms of the peptides in DMSO at a concentration of 125 mM. Following immediate mixing and sonication for three minutes, stock solutions were then diluted into the assay buffer in disposable plastic cuvettes (pathlength 1 cm) and at room temperature as follows: 40 ml of the peptide stock solution were added to a mixture of 920 ml of aqueous 10 mM sodium phosphate buffer (pH 7.4), and 40 ml of 20 mM sodium phosphate buffer (pH 7.4). Immediately thereafter, the solution was stirred by a magnetic stirring bar (3 mm Â 10 mm) and turbidity (absorbance at 400 nm) was measured over several time points. Aggregation assays were always performed in duplicate in the same experimental set and experiments were repeated in three independent experimental settings. Buffers were always sterile-®ltered (0.22 mm) prior to the experiment. Thermodynamic solubilities are the mean (AESEM) of three or four independent aggregation experiments, performed as descibed above and were determined four days following the start of the aggregation experiment as follows: peptide suspensions were centrifuged (12,000 g) for ten minutes, supernatants recovered and remaining soluble peptide quanti®ed by RP-HPLC analysis using various concentrations of the respective peptide as calibration standards. Pellets were dried over KOH platlets and suspended in water, 2 H 2 O, or cell culture medium at 2.6-5 mg/ml, depending on the sequence (apparent concentration of 5 mM) to be used for the AFM, FT-IR, and cytotoxicity studies, respectively.
Seeding experiments were performed parallel with aggregation assays of non-seeded solutions and the same stock solutions were used for both assays to exclude possible variations of the lag-time due to different stocks (Harper & Lansbury, 1997; Kapurniotu et al., 1998; Kayed et al., 1999) . Because we wanted to probe the nucleation dependence of aggregation of the hIAPP fragments, it was necessary to identify conditions above the saturation level of the peptide solutions that lead to peptide aggregation after a signi®cant lag-time (Harper & Lansbury, 1997) . Therefore, hIAPP(22-27) (NFGAIL) was applied at 2.4 mg/ml (apparent concentration of 3.75 mM) which resulted in a signi®cant aggregation lag-time (ten hours). Both, the aggregation and seeding experiments of the 2.4 mg/ml hIAPP(22-27) solution were performed in 10 mM sodium phosphate buffer (pH 7.4), containing 2 % DMSO and about 0.24 mg/ml (10 %) preformed hIAPP(22-27) (NFGAIL) ®brils. The seeding experiment of hIAPP(23-27) (FGAIL) was performed at 2.6 mg/ml peptide (apparent concentration of 5 mM) with 0.26 mg/ml (10 %) preformed hIAPP(23-27) ®brils as described above. At this peptide concentration insoluble amyloid formation in an unseeded solution set in after a lag-time of about 32 hours.
The results of several turbidity assays were con®rmed by the CR binding assay (Benditt et al., 1970; Klunk et al., 1989a,b) which was performed as follows: at various time points, aliquots (40 ml) of solutions used for turbidity measurements were removed and mixed with 40 ml of a 25 mM CR solution in 10 mM potassium phosphate buffer (pH 7.4), containing 150 mM NaCl, reactions incubated for 30 minutes at room temperature and bound CR determined as described (Benditt et al., 1970; Klunk et al., 1989a; Wood et al., 1996) .
FT-IR spectroscopy
Insoluble aggregates formed after four days in a kinetic aggregation experiment, were collected, quanti®ed, and dried as described above. They were resuspended in 2 H 2 O at an apparent concentration of 5 mM, applied onto a CaF 2 plate and air-dried. Spectra were measured in a Perkin-Elmer spectrophotometer (Spectrum 1000). Spectra of non-amyloidogenic peptides were measured after incubation of 10 mM solutions in 2 H 2 O for four days at room temperature. The aged solutions were then applied onto a CaF 2 plate, air-dried, and measured. The same peptide preparations that were used for all other assays were applied also for the FT-IR studies and no additional puri®cation steps of the HPLC-puri®ed peptides were performed to replace potential TFA counterions by cloride. Such TFA-replacing procedures are usually performed to exclude the presence of absorbance bands of TFA in the IR spectrum (Moriarty & Raleigh, 1999) . However, we reasoned that all biophysical and conformational studies on one sequence should be performed with a chemically identical peptide preparation to avoid possible effects of different counterions on the properties of the peptide. In fact, it has often been demonstrated that biophysical, conformational, and also cytotoxic properties of amyloidogenic peptides may vary dramatically depending on the solvents or salts used for their preparation (Kaneko & Tutumi, 1997; Shen & Murphy, 1995) . Since no basic residues are present in the sequences studied here, our FT-IR studies should reasonably allow for a comparative and qualitative study of the secondary structure differences between the ®brillar forms of the peptides.
Electron microscopy
Incubations of peptides at 1.8-10 mg/ml (apparent concentrations of 5 to 10 mM) were performed in 10 mM sodium phosphate buffer (pH 7.4), for six days at room temperature. Formation of ®brils was assessed after three and six days of incubation as recently described by Kayed et al. (1999) using a Zeiss EM 109 electron microscope operated at 80 kV.
Atomic force microscopy (AFM)
The insoluble aggregates formed in 50 ml of a kinetic aggregation experiment (apparent concentration of 5 mM) were collected and resuspended in H 2 O at a ®nal concentration of 5 mM. The non-amyloidogenic peptides hIAPP(24-27) (GAIL) and the rIAPP sequences were dissolved at peptide concentrations of 10 mM in water and aged for four days before AFM examination. Following dilution down to micromolar concentrations, 5 ml was placed on a square cover glass (15 mm Â 15 mm) and then air-dried. Images were obtained with an AUTOP-ROBE CP Microscope (Park Scienti®c Instruments, Sunnyvale, CA) and the non-contact-mode technique essentially as recently described (Kayed et al., 1999) . The scanning parameters applied for the images presented in the Figures were drive amplitude between 8 and 19 V and scan rate between 1.2 and 1.5 Hz. Diameters of the ®brils and dimensions of the aggregates were determined as recently described (Kayed et al., 1999; Harper et al., 1997b; Stine et al., 1996) .
Congo red staining
A 10 ml aliquot of an aged supersaturated peptide suspension or an aged highly concentrated solution (1.8-10 mg/ml, apparent concentrations of 5-10 mM) in 10 mM sodium phosphate buffer (pH 7.4), four days incubation, or a 10 ml aliquot of a kinetic aggregation assay suspension after peptide insolubilization was completed (four days) was allowed to air-dry on a glass microscope slide. Staining was performed by the addition of a solution of 1 mM CR in 100 mM NaCl and 10 mM sodium phosphate buffer (pH 7.4), followed by drying of the solution and rinsing with double-distilled water to remove excess CR (Jarrett & Lansbury, 1992) or by the addition of a saturated CR solution in 80 % (v/v) ethanol (McLean & Balasubramaniam, 1992) . The former method was applied for peptides hIAPP(22-27) and (23-27) and the latter for the staining of the highly water-soluble peptide hIAPP(24-27) (done at a peptide concentration of 25 mM) and the rest of the peptides. Birefringence was determined with an OLYMPUS BH2 light microscope (Olympus, Tokyo, Japan) under polarized light.
In vitro cytotoxicity studies
The rat insulinoma cell line RIN5fm was obtained by T. E. Rucinsky from the Washington University Tissue Culture Support Center and was cultured in RPMI 1640 containing 10 % heat-inactivated fetal bovine serum, 2 mM L-glutamine, 0.1 mM non-essential amino acids, 1 mg/ml glucose, 1 mM sodium pyruvate, and 0.1 mg/ ml penicillin/streptomycin. Cells were plated in 96-well plates at a density of 5 Â 10 5 cells/ml (100 ml/well). Following incubation for 24 hours (37 C, humidi®ed atmosphere with 5 % CO 2 ), serial dilutions of the suspensions of the peptide ®brils isolated and quanti®ed from the kinetic aggregation experiments as described above or of the freshly dissolved peptides were made in cell culture medium and 11 ml added into each well. Incubations were performed for about 20 hours and cell viability was then assessed by measuring the cellular reduction of MTT (Kapurniotu et al., 1998; Shearman et al., 1994) .
